Login to Your Account



Phase II Success For ONYX-015 Tumor Killer Prompts Phase III Trial In Head And Neck Cancer


Wednesday, August 2, 2000
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription